Digg It
#1 in Business Subscribe Email Print

You are here: Home > Business > Management > Executive Humor at Meetings

Tags

  • packaged
  • where
  • product
  • biological product
  • companies involved

  • Links

  • The World Cup is Drumming Up Amazing Amounts of Finance this Summer
  • Supersize That Article: Fast Food for Thought
  • Obtaining a Mortgage Loan if You Have Bad Credit
  • Digg It - Executive Humor at Meetings

    I don't encourage managers to wear funny hats, appear in self-deprecating skits
    According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
    , or otherwise emulate Saturday Night Live in an attempt to manufacture an imag
    ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

    Examples of combination products may in
    e as, "Look, folks! I'm just one a' the guys!" If clients insist, I do what I c
    lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

    an to help. I want the money. But it's not usually such a hot idea.

    I know it'
    here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
    s done. Frequently. And I read reports of the exhilarating effects created by e
    d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

    Combination pro
    xecutives who deliver call-to-action keynotes dressed as a gunfighter or sumo w
    ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
    restler. I notice, also, that these reports are usually written by those who wo
    easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
    rk for the speaker, or by meeting producers retained by the speaker's company.
    nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

    A field sales force may see their management only once or twice a year; usuall
    and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
    y at the annual sales meeting. They need to know that those running the store h
    ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
    ave a clear vision of where the company's going, and what it will take to get i
    ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

    Following aspects would a
    t there. And giving them Bozo the clown doesn't do a hell of a lot to convince
    dd to the challenges in developing combination products:

    Which markets to tap where the combination products can do fairly well?
    Which combination prod
    a sales force their future is in good hands.

    Conventional wisdom tells us the
    cts are meaningful and rational?
    Which therapeutic categories to select?
    Which Combinations can address unmet needs of the patients?
    Do combin
    confident and secure executive isn't compromised by a little benign buffoonery.
    tions increase the patient compliance?
    What would be the developing cost?
    How to tackle the risks encountered during combination product developmen
    Well, maybe. In my experience, however, confident managers are secure enough t
    t?

    As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
    o bypass situations that often succeed in converting respect to ridicule. It's
    ping new procedures for reviewing their safety, efficacy and quality.

    Professional from academic institutions, pharmaceutical industries, health care indust
    usually the uncertain manager who clutches at these moments in an attempt to cr
    y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
    eate a public charisma that personal performance has never provided.

    The botto
    .

    As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.diggit.org.ua/article/24789/diggit-Executive-Humor-at-Meetings.html">Executive Humor at Meetings</a>

    BB link (for phorums):
    [url=http://www.diggit.org.ua/article/24789/diggit-Executive-Humor-at-Meetings.html]Executive Humor at Meetings[/url]

    Related Articles:

    Subliminal Advertising: Does It Exist?

    Are You Bored By What You Do?

    Decking the Halls While Running Your Business

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com